Principal Financial Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.5M | Sell |
1,030,527
-117,765
| -10% | -$5.09M | 0.02% | 496 |
|
|
2025
Q1 | $39.7M | Buy |
1,148,292
+98,153
| +9% | +$3.39M | 0.02% | 513 |
|
|
2024
Q4 | $28.8M | Sell |
1,050,139
-94,984
| -8% | -$2.61M | 0.02% | 665 |
|
|
2024
Q3 | $29.2M | Buy |
1,145,123
+19,978
| +2% | +$509K | 0.02% | 652 |
|
|
2024
Q2 | $28.5M | Buy |
1,125,145
+51,958
| +5% | +$1.32M | 0.02% | 671 |
|
|
2024
Q1 | $33.2M | Buy |
1,073,187
+129,703
| +14% | +$4.01M | 0.02% | 633 |
|
|
2023
Q4 | $38.1M | Buy |
943,484
+197,818
| +27% | +$7.99M | 0.02% | 538 |
|
|
2023
Q3 | $19.7M | Buy |
745,666
+705,249
| +1,745% | +$18.6M | 0.01% | 813 |
|
|
2023
Q2 | $695K | Buy |
40,417
+6,946
| +21% | +$119K | ﹤0.01% | 1893 |
|
|
2023
Q1 | $555K | Buy |
33,471
+474
| +1% | +$7.86K | ﹤0.01% | 1949 |
|
|
2022
Q4 | $251K | Buy |
32,997
+2,378
| +8% | +$18.1K | ﹤0.01% | 2144 |
|
|
2022
Q3 | $305K | Buy |
30,619
+1,907
| +7% | +$19K | ﹤0.01% | 2075 |
|
|
2022
Q2 | $260K | Sell |
28,712
-4,371
| -13% | -$39.6K | ﹤0.01% | 2224 |
|
|
2022
Q1 | $336K | Sell |
33,083
-275
| -0.8% | -$2.79K | ﹤0.01% | 2209 |
|
|
2021
Q4 | $556K | Sell |
33,358
-14,816
| -31% | -$247K | ﹤0.01% | 2103 |
|
|
2021
Q3 | $2.26M | Sell |
48,174
-2,294
| -5% | -$108K | ﹤0.01% | 1846 |
|
|
2021
Q2 | $3.08M | Buy |
50,468
+2,922
| +6% | +$178K | ﹤0.01% | 1822 |
|
|
2021
Q1 | $2.93M | Buy |
47,546
+3,859
| +9% | +$238K | ﹤0.01% | 1786 |
|
|
2020
Q4 | $3.11M | Buy |
43,687
+6,879
| +19% | +$489K | ﹤0.01% | 1697 |
|
|
2020
Q3 | $1.38M | Sell |
36,808
-1,956
| -5% | -$73.4K | ﹤0.01% | 1808 |
|
|
2020
Q2 | $1.26M | Buy |
38,764
+29,660
| +326% | +$967K | ﹤0.01% | 1782 |
|
|
2020
Q1 | $264K | Buy |
+9,104
| New | +$264K | ﹤0.01% | 1994 |
|